Dafna D Gladman, MD, FRCPC

Senior Scientist, Krembil Research Institute (Krembil)
*This is not a trusted UHN email destination.
https://orcid.org/0000-0002-9074-0592
Keywords: psoriatic arthritis, systemic lupus erythematosus (SLE), rheumatoid arthritis
Prognosis, genetic and theraupeutic studies in the rheumatic diseases particularly:
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

Related Links

Associated Program(s)
Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.
JACC Cardiovasc Imaging. 2019 Nov 06;:
Hanneman K, Alberdi HV, Karur GR, Tselios K, Harvey PJ, Gladman DD, Akhtari S, Osuntokun T, Wald RM, Thavendiranathan P, Butany J, Urowitz MB
Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).
Arthritis Rheumatol. 2019 Oct 21;:
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M,...
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
J Autoimmun. 2019 Oct 17;:102340
Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS,...
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
J Rheumatol. 2019 Oct 15;:
Orbai AM, McInnes IB, Coates LC, Husni ME, Gladman DD, Gossec L, Pricop L, Chambenoit O, Meng X, Mease PJ
Liver Abnormalities in Patients with Psoriatic Arthritis.
J Rheumatol. 2019 Oct 15;:
Pakchotanon R, Ye Y, Cook RJ, Chandran V, Gladman DD
Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.
Arthritis Care Res (Hoboken). 2019 Oct 14;:
Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey...
Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Rheumatology (Oxford). 2019 Oct 08;:
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD
Psoriatic arthritis.
F1000Res. 2019;8:
Ocampo D V, Gladman D
Measurement properties of the minimal disease activity criteria for psoriatic arthritis.
RMD Open. 2019;5(2):e001002
Coates LC, Strand V, Wilson H, Revicki D, Stolshek B, Samad A, Chung JB, Gladman D, Mease PJ
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1).
J Rheumatol. 2018 03;45(3):367-377
van der Heijde D, Gladman DD, Kishimoto M, Okada M, Rathmann SS, Moriarty SR, Shuler CL, Carlier H, Benichou O, Mease PJ

Pages


 
Senior Scientist, Krembil Research Institute (Krembil)

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH